Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA

Miyuki Takahashi, Manami Ishida, Taro Saito, Toshio Ohshima, Shin Ichi Hisanaga

    Research output: Contribution to journalArticle

    6 Citations (Scopus)

    Abstract

    The cyclin-dependent kinase 5 (Cdk5) is a neuron-specific Ser/Thr kinase that is activated by the regulatory subunit p35. Overactivation of Cdk5, which is induced by the cleavage of p35 by calpain, is implicated in neuronal death in various neurodegenerative diseases. In contrast, depletion of the Cdk5 activity renders neurons vulnerable to stresses. Recent reports suggest the involvement of Cdk5 in mental disorders. We hypothesized that perturbation of Cdk5 activity is related to mental conditions. To verify this hypothesis, we investigated the effect of valproic acid (VPA), which is a drug of choice for psychiatric disorders, on Cdk5 activity. VPA decreased the expression of p35 at both the protein and mRNA levels in cultured neurons, resulting in a decrease of Cdk5 activity. VPA decreased the p35 mRNA via histone deacetylase inhibition. The chronic administration of VPA also downregulated p35 in mouse brains. These results indicate that VPA regulates Cdk5 activity in neurons via p35 transcription mediated by HDAC inhibition.

    Original languageEnglish
    Pages (from-to)678-682
    Number of pages5
    JournalBiochemical and Biophysical Research Communications
    Volume447
    Issue number4
    DOIs
    Publication statusPublished - 2014 May 16

    Fingerprint

    Cyclin-Dependent Kinase 5
    Valproic Acid
    Transcription
    Down-Regulation
    Messenger RNA
    Neurons
    Neurodegenerative diseases
    Calpain
    Histone Deacetylases
    Mental Disorders
    Neurodegenerative Diseases
    Psychiatry
    Brain
    Phosphotransferases

    Keywords

    • Autism
    • Cdk5
    • HDAC
    • p35
    • Transcription
    • Valproic acid

    ASJC Scopus subject areas

    • Biochemistry
    • Biophysics
    • Cell Biology
    • Molecular Biology

    Cite this

    Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA. / Takahashi, Miyuki; Ishida, Manami; Saito, Taro; Ohshima, Toshio; Hisanaga, Shin Ichi.

    In: Biochemical and Biophysical Research Communications, Vol. 447, No. 4, 16.05.2014, p. 678-682.

    Research output: Contribution to journalArticle

    Takahashi, Miyuki ; Ishida, Manami ; Saito, Taro ; Ohshima, Toshio ; Hisanaga, Shin Ichi. / Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA. In: Biochemical and Biophysical Research Communications. 2014 ; Vol. 447, No. 4. pp. 678-682.
    @article{2abbff75c5594a6da696ca38289f51d4,
    title = "Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA",
    abstract = "The cyclin-dependent kinase 5 (Cdk5) is a neuron-specific Ser/Thr kinase that is activated by the regulatory subunit p35. Overactivation of Cdk5, which is induced by the cleavage of p35 by calpain, is implicated in neuronal death in various neurodegenerative diseases. In contrast, depletion of the Cdk5 activity renders neurons vulnerable to stresses. Recent reports suggest the involvement of Cdk5 in mental disorders. We hypothesized that perturbation of Cdk5 activity is related to mental conditions. To verify this hypothesis, we investigated the effect of valproic acid (VPA), which is a drug of choice for psychiatric disorders, on Cdk5 activity. VPA decreased the expression of p35 at both the protein and mRNA levels in cultured neurons, resulting in a decrease of Cdk5 activity. VPA decreased the p35 mRNA via histone deacetylase inhibition. The chronic administration of VPA also downregulated p35 in mouse brains. These results indicate that VPA regulates Cdk5 activity in neurons via p35 transcription mediated by HDAC inhibition.",
    keywords = "Autism, Cdk5, HDAC, p35, Transcription, Valproic acid",
    author = "Miyuki Takahashi and Manami Ishida and Taro Saito and Toshio Ohshima and Hisanaga, {Shin Ichi}",
    year = "2014",
    month = "5",
    day = "16",
    doi = "10.1016/j.bbrc.2014.04.072",
    language = "English",
    volume = "447",
    pages = "678--682",
    journal = "Biochemical and Biophysical Research Communications",
    issn = "0006-291X",
    publisher = "Academic Press Inc.",
    number = "4",

    }

    TY - JOUR

    T1 - Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA

    AU - Takahashi, Miyuki

    AU - Ishida, Manami

    AU - Saito, Taro

    AU - Ohshima, Toshio

    AU - Hisanaga, Shin Ichi

    PY - 2014/5/16

    Y1 - 2014/5/16

    N2 - The cyclin-dependent kinase 5 (Cdk5) is a neuron-specific Ser/Thr kinase that is activated by the regulatory subunit p35. Overactivation of Cdk5, which is induced by the cleavage of p35 by calpain, is implicated in neuronal death in various neurodegenerative diseases. In contrast, depletion of the Cdk5 activity renders neurons vulnerable to stresses. Recent reports suggest the involvement of Cdk5 in mental disorders. We hypothesized that perturbation of Cdk5 activity is related to mental conditions. To verify this hypothesis, we investigated the effect of valproic acid (VPA), which is a drug of choice for psychiatric disorders, on Cdk5 activity. VPA decreased the expression of p35 at both the protein and mRNA levels in cultured neurons, resulting in a decrease of Cdk5 activity. VPA decreased the p35 mRNA via histone deacetylase inhibition. The chronic administration of VPA also downregulated p35 in mouse brains. These results indicate that VPA regulates Cdk5 activity in neurons via p35 transcription mediated by HDAC inhibition.

    AB - The cyclin-dependent kinase 5 (Cdk5) is a neuron-specific Ser/Thr kinase that is activated by the regulatory subunit p35. Overactivation of Cdk5, which is induced by the cleavage of p35 by calpain, is implicated in neuronal death in various neurodegenerative diseases. In contrast, depletion of the Cdk5 activity renders neurons vulnerable to stresses. Recent reports suggest the involvement of Cdk5 in mental disorders. We hypothesized that perturbation of Cdk5 activity is related to mental conditions. To verify this hypothesis, we investigated the effect of valproic acid (VPA), which is a drug of choice for psychiatric disorders, on Cdk5 activity. VPA decreased the expression of p35 at both the protein and mRNA levels in cultured neurons, resulting in a decrease of Cdk5 activity. VPA decreased the p35 mRNA via histone deacetylase inhibition. The chronic administration of VPA also downregulated p35 in mouse brains. These results indicate that VPA regulates Cdk5 activity in neurons via p35 transcription mediated by HDAC inhibition.

    KW - Autism

    KW - Cdk5

    KW - HDAC

    KW - p35

    KW - Transcription

    KW - Valproic acid

    UR - http://www.scopus.com/inward/record.url?scp=84900385043&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84900385043&partnerID=8YFLogxK

    U2 - 10.1016/j.bbrc.2014.04.072

    DO - 10.1016/j.bbrc.2014.04.072

    M3 - Article

    C2 - 24755075

    AN - SCOPUS:84900385043

    VL - 447

    SP - 678

    EP - 682

    JO - Biochemical and Biophysical Research Communications

    JF - Biochemical and Biophysical Research Communications

    SN - 0006-291X

    IS - 4

    ER -